Chinese Companies & Investors Seeking Partners and Valuable Assets

by | Apr 29, 2019 | China Focus, Competition


Opportunities in China

Currently we are actively helping Chinese clients seek strategic partners. Contact us if your product is falling into these categories and you are interested in exploring potential possibilities in China market.

  • Bispecific antibody/ADC drugs. A few recent successful partnership cases are as follows:
  1. Abpro and China’s NJCTTQ Ink $4 Billion Development Deal.
  2. Shanghai Miracogen will pay up to €111M ($125M) to develop cancer treatments based on antibody-drug conjugate technology from the Dutch company Synaffix.
  3. MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize MGD013 and TRIDENT Molecule in Greater China.
  • Orthopedics medical devices/consumables. Biocompatible bone cement, arthroscope, and Cross-linked hyaluronan injection for osteoarthritis (Synvisc-One similar products), are highly desired.
More Opportunities Available


We are going to bring together 100+ Chinese executives from pharma, medical device companies and investment institutions in Philadelphia. A few newly confirmed speakers are as follows:
Wensen Wendy Pan Partner, Sidley Austin LLP

Recognized by IFLR1000 as a leading lawyer for M&A. Has advised on mergers and acquisitions transactions with an aggregate value over US$10 billion.

Dan Zhang Executive Chairman, Fountain Medical Development Ltd.
A clinical CRO with 1700 employees operating in Greater China, South Korea, Japan, UK, India, Philippines, Armenia & USA.
Andy Li
President & CEO, BioSense Suzhou Global
Newly announced a collaboration and license agreement with Rexahn, a Maryland-based biopharma.
Derrick Li Head of Strategy and Investor Relations, Cellular Biomedicine Group, Inc.
A NASDAQ-listed clinical-stage biopharmaceutical firm that develops cell therapies for the treatment of cancer and degenerative diseases.
Xi-Yong Sean Fu President, Luye Boston R&D LLC, USA
The discovery engine for Luye Pharma with a focus on international R&D collaboration.
Register to Schedule 1-1 Meeting with Other Attendees

Innovation Competition

MyBioGate Global Healthcare Innovation Competition is still accepting applications! Click here to learn more about preliminary schedule and featured prizes.


Upcoming Preliminaries: 

  • April 30, Online zoom webinar
    • Time: April 30, 10:00 AM (GMT +8, Beijing, Shanghai)
    • Register in advance for this webinar:
  • June 2, Philadelphia
    • 1-to-1 partnering opportunities with potential Chinese investors.
    • Exhibition space for your company at China Focus@BIO Philadelphia with a surprise discount.
Submit Application Now

Shortlist for 4.30 Online Preliminary

Partner Event